173
Views
112
CrossRef citations to date
0
Altmetric
Research Article

Coenzyme Q 10 as a Possible Treatment for Neurodegenerative Diseases

Pages 455-460 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Şeref Şimşek, İbrahim Kaplan, Cem Uysal, Tuğba Yüksel & Rümeysa Alaca. (2016) The Levels of Cortisol, Oxidative Stress, and DNA Damage in the Victims of Childhood Sexual Abuse: A Preliminary Study. Journal of Child Sexual Abuse 25:2, pages 175-184.
Read now
Engy M. El Morsy, Rehab Kamel & Maha A. E. Ahmed. (2015) Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats. Immunopharmacology and Immunotoxicology 37:3, pages 244-251.
Read now
John A Morren & Nestor Galvez-Jimenez. (2012) Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 21:3, pages 297-320.
Read now
Sun Young Jung, Eun Young Kang, Yoon Jung Choi, In Koo Chun, Byung Koo Lee & Hye Sun Gwak. (2009) Formulation and evaluation of ubidecarenone transdermal delivery systems. Drug Development and Industrial Pharmacy 35:9, pages 1029-1034.
Read now
Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi & Gen Sobue. (2008) A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. Expert Opinion on Pharmacotherapy 9:11, pages 1845-1857.
Read now
Hemmi N. Bhagavan & Raj K. Chopra. (2006) Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research 40:5, pages 445-453.
Read now
Beatrice Alexandra Golomb. (2005) Implications of statin adverse effects in the elderly. Expert Opinion on Drug Safety 4:3, pages 389-397.
Read now
AYFER YALCIN, EMRAH KILINC, SEMRA KOCTURK, HALIL RESMI & ESER Y. SOZMEN. (2004) EFFECT OF MELATONIN COTREATMENT AGAINST KAINIC ACID ON COENZYME Q10, LIPID PEROXIDATION AND TRX mRNA IN RAT HIPPOCAMPUS. International Journal of Neuroscience 114:9, pages 1085-1097.
Read now
Steven K Baker & Mark A Tarnopolsky. (2003) Targeting cellular energy production in neurological disorders. Expert Opinion on Investigational Drugs 12:10, pages 1655-1679.
Read now
Mandy Jackson, Jerònia Lladó & Jeffrey D Rothstein. (2002) Therapeutic developments in the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 11:10, pages 1343-1364.
Read now
Angela Genge, Steven Wainwright & Christine Vande Velde. Amyotrophic lateral sclerosis: exploring pathophysiology in the context of treatment. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-12.
Read now

Articles from other publishers (99)

Kathleen E. Murray, Whitney A. Ratliff, Vedad Delic & Bruce A. Citron. (2024) Gulf War toxicant-induced reductions in dendritic arbors and spine densities of dentate granule cells are improved by treatment with a Nrf2 activator. Brain Research 1823, pages 148682.
Crossref
Sally A Abuelezz & Nevien Hendawy. (2023) Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB. Journal of Pharmacy and Pharmacology 75:8, pages 1119-1129.
Crossref
Masoumeh Asadbegi, Hamidreza Komaki, Nafiseh Faraji, Masoumeh Taheri, Samaneh Safari, Safoura Raoufi, Masoumeh Kourosh-Arami, Zoleikha Golipoor & Alireza Komaki. (2023) Effectiveness of coenzyme Q10 on learning and memory and synaptic plasticity impairment in an aged Aβ-induced rat model of Alzheimer’s disease: a behavioral, biochemical, and electrophysiological study. Psychopharmacology 240:4, pages 951-967.
Crossref
Deepti Katiyar, Shipra Singhal, Priya Bansal, K. Nagarajan & Parul Grover. (2023) Nutraceuticals and phytotherapeutics for holistic management of amyotrophic lateral sclerosis. 3 Biotech 13:2.
Crossref
Sarah Hassan, Mario Eid, Ahmad Hassan & Samer El Hayek. 2023. Trace Elements in Brain Health and Diseases. Trace Elements in Brain Health and Diseases 155 168 .
Siva Prasad Panda & Urvashi Soni. (2022) A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities. Ageing Research Reviews 75, pages 101560.
Crossref
Mamtaj Alam, Rajeshwar K. Yadav, Elizabeth Minj, Aarti Tiwari & Sidharth Mehan. (2021) Exploring Molecular Approaches in Amyotrophic Lateral Sclerosis: Drug Targets from Clinical and Pre-Clinical Findings. Current Molecular Pharmacology 14:3, pages 263-280.
Crossref
Arpita Arora, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Bijo Mathew & Simona Bungau. (2021) Targeting cellular batteries for the therapy of neurological diseases. Environmental Science and Pollution Research 28:31, pages 41517-41532.
Crossref
Jessica R. Morrice, Michael Kuo & Christopher A. Shaw. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis 181 199 .
Beatriz Fernández-Vega, Javier Nicieza, Ana Álvarez-Barrios, Lydia Álvarez, Montserrat García, Carlos Fernández-Vega, José A. Vega & Héctor González-Iglesias. (2020) The Use of Vitamins and Coenzyme Q10 for the Treatment of Vascular Occlusion Diseases Affecting the Retina. Nutrients 12:3, pages 723.
Crossref
Qian Cai & Yu Young Jeong. (2020) Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases. Cells 9:1, pages 150.
Crossref
Gerwyn Morris, Basant K. Puri, Adam J. Walker, Michael Berk, Ken Walder, Chiara C. Bortolasci, Wolfgang Marx, Andre F. Carvalho & Michael Maes. (2019) The compensatory antioxidant response system with a focus on neuroprogressive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 95, pages 109708.
Crossref
Daniela Sayuri Mizobuti, Aline Reis Fogaça, Fernanda dos Santos Rapucci Moraes, Luis Henrique Rapucci Moraes, Rafael Dias Mâncio, Túlio de Almeida Hermes, Aline Barbosa Macedo, Amanda Harduim Valduga, Caroline Caramano de Lourenço, Elaine Cristina Leite Pereira & Elaine Minatel. (2019) Coenzyme Q10 supplementation acts as antioxidant on dystrophic muscle cells. Cell Stress and Chaperones 24:6, pages 1175-1185.
Crossref
E. ThuesonD.P. LeadonR. HeatonI.P. HargreavesW.M. Bayly. (2019) Effect of daily supplementation with ubiquinol on muscle coenzyme Q10 concentrations in Thoroughbred racehorses. Comparative Exercise Physiology 15:3, pages 219-226.
Crossref
Angelo Michele CARELLA, Teresa MARİNELLİ, Michele Dİ PUMPO, Giovanni MODOLA & Angelo BENVENUTO. (2019) Coenzyme Q10 deficiency in elderly: Can nutritional supplementation play a role? Mini review. The European Research Journal 5:1, pages 166-173.
Crossref
Farzad Salehpour, Fereshteh Farajdokht, Paolo Cassano, Saeed Sadigh-Eteghad, Marjan Erfani, Michael R. Hamblin, Maryam Moghadam Salimi, Pouran Karimi, Seyed Hossein Rasta & Javad Mahmoudi. (2019) Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis. Brain Research Bulletin 144, pages 213-222.
Crossref
Marwa M. Nagib, Mariane G. Tadros, Hadwa Ali Abd Al-khalek, Rania M. Rahmo, Nagwa Ali Sabri, Amani E. Khalifa & Somaia I. Masoud. (2018) Molecular mechanisms of neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: Impact on Sirt1/NRF2 signaling pathways. NeuroToxicology 68, pages 47-65.
Crossref
Navneet Ammal Kaidery & Bobby Thomas. (2018) Current perspective of mitochondrial biology in Parkinson's disease. Neurochemistry International 117, pages 91-113.
Crossref
Juan D. Hernández-Camacho, Michel Bernier, Guillermo López-Lluch & Plácido Navas. (2018) Coenzyme Q10 Supplementation in Aging and Disease. Frontiers in Physiology 9.
Crossref
Sally A. Abuelezz, Nevien Hendawy & Yosra Magdy. (2018) The potential benefit of combined versus monotherapy of coenzyme Q10 and fluoxetine on depressive-like behaviors and intermediates coupled to Gsk-3β in rats. Toxicology and Applied Pharmacology 340, pages 39-48.
Crossref
A. Weerasekera, D.M. Sima, T. Dresselaers, S. Van Huffel, P. Van Damme & U. Himmelreich. (2018) Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1G93A mouse model: A 1H-magnetic resonance spectroscopic study. NeuroImage: Clinical 20, pages 1092-1105.
Crossref
Zhaoqiang Zhang, Limin Shi, Xixun Du, Qian Jiao & Hong Jiang. (2017) Acute action of rotenone on excitability of catecholaminergic neurons in rostral ventrolateral medulla. Brain Research Bulletin 134, pages 151-161.
Crossref
Sally A. Abuelezz, Nevien Hendawy & Yosra Magdy. (2016) Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats. Journal of Neuroimmune Pharmacology 12:2, pages 277-291.
Crossref
Dmitry Petrov, Colin Mansfield, Alain Moussy & Olivier Hermine. (2017) ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?. Frontiers in Aging Neuroscience 9.
Crossref
Xiao-Han Zhao & Chuan-He Tang. (2016) Spray-drying microencapsulation of CoQ 10 in olive oil for enhanced water dispersion, stability and bioaccessibility: Influence of type of emulsifiers and/or wall materials. Food Hydrocolloids 61, pages 20-30.
Crossref
Şeref Şimşek, Salih Gençoğlan & Tuğba Yüksel. (2016) DNA damage and antioxidants in treatment naïve children with obsessive–compulsive disorder. Psychiatry Research 237, pages 133-137.
Crossref
Şeref ŞimsekTuğba Yükselİbrahim KaplanCem UysalHüseyin Aktaş. (2016) The Levels of Cortisol and Oxidative Stress and DNA Damage in Child and Adolescent Victims of Sexual Abuse with or without Post-Traumatic Stress Disorder. Psychiatry Investigation 13:6, pages 616.
Crossref
Şeref Şimşek, Salih Gençoğlan, Tuğba Yüksel, İbrahim Kaplan, Rümeysa Alaca & Hüseyin Aktaş. (2016) Oxidative Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents. Neuropsychobiology 73:2, pages 92-97.
Crossref
Beena M. Kadakkuzha, Xin-an Liu, Supriya Swarnkar & Youjun Chen. 2016. Nutraceuticals. Nutraceuticals 227 237 .
Valentin K. Gribkoff. 2015. The Functions, Disease-Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria. The Functions, Disease-Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria 295 321 .
Huaiqiong Chen, Yongguang Guan & Qixin Zhong. (2015) Microemulsions Based on a Sunflower Lecithin–Tween 20 Blend Have High Capacity for Dissolving Peppermint Oil and Stabilizing Coenzyme Q 10 . Journal of Agricultural and Food Chemistry 63:3, pages 983-989.
Crossref
Rebecca Banerjee, Navneet Ammal Kaidery & Bobby Thomas. 2015. Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2. Oxidative Stress: Diagnostics, Prevention, and Therapy Volume 2 147 176 .
Csilla Ari, Angela M. Poff, Heather E. Held, Carol S. Landon, Craig R. Goldhagen, Nicholas Mavromates & Dominic P. D’Agostino. (2014) Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model. PLoS ONE 9:7, pages e103526.
Crossref
Brian D. Tobin, Maurice G. O'Sullivan, Ruth Hamill & Joseph P. Kerry. (2014) European consumer attitudes on the associated health benefits of neutraceutical-containing processed meats using Co-enzyme Q10 as a sample functional ingredient. Meat Science 97:2, pages 207-213.
Crossref
Brian D. Tobin, Maurice G. O’Sullivan, Ruth Hamill & Joseph P. Kerry. (2014) Effect of cooking and in vitro digestion on the stability of co-enzyme Q10 in processed meat products. Food Chemistry 150, pages 187-192.
Crossref
Gerwyn Morris, George Anderson, Michael Berk & Michael Maes. (2013) Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications. Molecular Neurobiology 48:3, pages 883-903.
Crossref
Sawsan Aboul-Fotouh. (2013) Chronic treatment with coenzyme Q10 reverses restraint stress-induced anhedonia and enhances brain mitochondrial respiratory chain and creatine kinase activities in rats. Behavioural Pharmacology 24:7, pages 552-560.
Crossref
Alexander N. Shikov, Olga N. Pozharitsk, Maria A. Kovaleva, Marina N. Makarova & Valery G. Makarov. (2013) Neurobehavioral Effects of the Intragastric Administration of Coenzyme Q10 Binary Solid Dispersion Tablets in Mice. Pharmacologia 4:9, pages 529-534.
Crossref
Michelle McDonagh. (2013) Nutritional and Metabolic Support in Adults With Amyotrophic Lateral Sclerosis. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) 22:1, pages 12-16.
Crossref
Sawsan Aboul-Fotouh. (2013) Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats. Pharmacology Biochemistry and Behavior 104, pages 105-112.
Crossref
Yi Chang, Shu-Kuei Huang & Su-Jane Wang. (2012) Coenzyme Q10 Inhibits the Release of Glutamate in Rat Cerebrocortical Nerve Terminals by Suppression of Voltage-Dependent Calcium Influx and Mitogen-Activated Protein Kinase Signaling Pathway. Journal of Agricultural and Food Chemistry 60:48, pages 11909-11918.
Crossref
Wei Zhao, Merina Varghese, Prashant Vempati, Anastasiya Dzhun, Alice Cheng, Jun Wang, Dale Lange, Amanda Bilski, Irene Faravelli & Giulio Maria Pasinetti. (2012) Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease. PLoS ONE 7:11, pages e49191.
Crossref
Jérôme Lapointe, Ying Wang, Eve Bigras & Siegfried Hekimi. (2012) The submitochondrial distribution of ubiquinone affects respiration in long-lived Mclk1+/− mice . Journal of Cell Biology 199:2, pages 215-224.
Crossref
Eun-Ah Kim, Jong-Yea Kim, Hyun-Jung Chung & Seung-Taik Lim. (2012) Preparation of aqueous dispersions of coenzyme Q10 nanoparticles with amylomaize starch and its dextrin. LWT 47:2, pages 493-499.
Crossref
Mauro Cozzolino & Maria Teresa Carrì. (2012) Mitochondrial dysfunction in ALS. Progress in Neurobiology 97:2, pages 54-66.
Crossref
Bo Yuan, Chunling Liu, Pingwei Xu, Lin Lin, Cheng Pan, Linglan Wang & Haiyan Xu. (2011) Validated HPLC method for the quantitative determination of CoQ10 in dog plasma and its application to a pharmacokinetic study. Biomedical Chromatography 25:9, pages 1038-1044.
Crossref
Mahesh V. Bule & Rekha S. Singhal. (2011) Fermentation kinetics of production of ubiquinone-10 by Paracoccus dinitrificans NRRL B-3785: Effect of type and concentration of carbon and nitrogen sources. Food Science and Biotechnology 20:3, pages 607-613.
Crossref
Cynthia A. MassaadEric Klann. (2011) Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory. Antioxidants & Redox Signaling 14:10, pages 2013-2054.
Crossref
Hanan S. El-Abhar. (2010) Coenzyme Q10: A novel gastroprotective effect via modulation of vascular permeability, prostaglandin E2, nitric oxide and redox status in indomethacin-induced gastric ulcer model. European Journal of Pharmacology 649:1-3, pages 314-319.
Crossref
Harry G. Preuss, Bobby Echard, Debasis Bagchi, Dallas Clouatre & Nicholas V. Perricone. (2010) Influence of gel and powdered formulations of coenzyme Q10 on metabolic parameters in rats. Molecular and Cellular Biochemistry 340:1-2, pages 169-173.
Crossref
Guillermo López-Lluch, Juan Carlos Rodríguez-Aguilera, Carlos Santos-Ocaña & Plácido Navas. (2010) Is coenzyme Q a key factor in aging?. Mechanisms of Ageing and Development 131:4, pages 225-235.
Crossref
Hiroshi Kamisoyama, Kazuhisa Honda, Kanako Kitaguchi & Shin Hasegawa. (2010) Transfer of Dietary Coenzyme Q10 into the Egg Yolk of Laying Hens. The Journal of Poultry Science 47:1, pages 28-33.
Crossref
Barkha P. Patel & Mazen J. Hamadeh. (2009) Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clinical Nutrition 28:6, pages 604-617.
Crossref
Beatrice A. Golomb, Edwin K. Kwon, Sabrina Koperski & Marcella A. Evans. (2009) Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs. Drug Safety 32:8, pages 649-661.
Crossref
Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen‐Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven P. Novella, Terry Heiman‐Patterson, Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto & Bruce Levin. (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Annals of Neurology 66:2, pages 235-244.
Crossref
Anthony G. Payne. (2009) Experimental regimen targeting the ependyma slows disease progression in four patients with amyotrophic lateral sclerosis. Medical Hypotheses 72:5, pages 548-550.
Crossref
Amitabh Gupta, Valina L. Dawson & Ted M. Dawson. (2009) What causes cell death in Parkinson's disease?. Annals of Neurology 64:S2, pages S3-S15.
Crossref
R. Nageswara Rao, M.V. Narendra Kumar Talluri & Dhananjay D. Shinde. (2008) Simultaneous separation and determination of coenzyme Q10 and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS). Journal of Pharmaceutical and Biomedical Analysis 47:2, pages 230-237.
Crossref
Takahiko Murata, Chigumi Ohtsuka & Yasuo Terayama. (2008) Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis. Journal of the Neurological Sciences 267:1-2, pages 66-69.
Crossref
Steven M. Albert. (2008) Dyslipidemia in ALS. Neurology 70:13, pages 988-989.
Crossref
C.M. Sabliov & C.E. Astete. 2008. Delivery and Controlled Release of Bioactives in Foods and Nutraceuticals. Delivery and Controlled Release of Bioactives in Foods and Nutraceuticals 297 330 .
Irene van Balken & Irene Litvan. 2008. Dementias. Dementias 493 508 .
Tom Valeo. (2007) Is there a Link Between Statins, Coenzyme Q10, and ALS?. Neurology Today 7:15, pages 27-28.
Crossref
Hemmi N. Bhagavan & Raj K. Chopra. (2007) Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Mitochondrion 7, pages S78-S88.
Crossref
Sonia M. Hasan, Mary Joe & Waleed B. Alshuaib. (2007) Oxidative Stress Alters Physiological and Morphological Neuronal Properties. Neurochemical Research 32:7, pages 1169-1178.
Crossref
Hemmi N. Bhagavan, Raj K. Chopra, Neal E. Craft, Chureeporn Chitchumroonchokchai & Mark L. Failla. (2007) Assessment of coenzyme Q10 absorption using an in vitro digestion-Caco-2 cell model. International Journal of Pharmaceutics 333:1-2, pages 112-117.
Crossref
Xue-Li Cao, Ya-Tao Xu, Guang-Ming Zhang, Sheng-Meng Xie, Ying-Mao Dong & Yoichiro Ito. (2006) Purification of coenzyme Q10 from fermentation extract: High-speed counter-current chromatography versus silica gel column chromatography. Journal of Chromatography A 1127:1-2, pages 92-96.
Crossref
Sushil K. Sharma, Hesham El ReFaey & Manuchair Ebadi. (2006) Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10. Brain Research Bulletin 70:1, pages 22-32.
Crossref
Bryan Fuller, Dustin Smith, Amber Howerton & Dale Kern. (2006) Anti-inflammatory effects of CoQ10 and colorless carotenoids. Journal of Cosmetic Dermatology 5:1, pages 30-38.
Crossref
Karen Usdin & Michael Fry. 2006. Human Nucleotide Expansion Disorders. Human Nucleotide Expansion Disorders 279 287 .
Rabia B. Choudry & Merit E. Cudkowicz. (2005) Clinical Trials in Amyotrophic Lateral Sclerosis: The Tenuous Past and the Promising Future. The Journal of Clinical Pharmacology 45:12, pages 1334-1344.
Crossref
Manuchair Ebadi, Sushil Sharma, Sawitri Wanpen, Shaik Shavali & Hesham El ReFaey. 2005. Molecular Interventions in Lifestyle-Related Diseases. Molecular Interventions in Lifestyle-Related Diseases 127 153 .
M. G. Kadieva, É. T. Oganesyan & S. Kh. Mutsueva. (2005) Neurotoxins and medicinals for the treatment of Parkinson’s disease. Part 3: Drugs indirectly influencing the dopaminergic system (a review). Pharmaceutical Chemistry Journal 39:11, pages 565-573.
Crossref
Daniel J.M. Fernández-Ayala, Gloria Brea-Calvo, Guillermo López-Lluch & Plácido Navas. (2005) Coenzyme Q distribution in HL-60 human cells depends on the endomembrane system. Biochimica et Biophysica Acta (BBA) - Biomembranes 1713:2, pages 129-137.
Crossref
David A. Groneberg, Birgit Kindermann, Martin Althammer, Maja Klapper, Jürgen Vormann, Gian P. Littarru & Frank Döring. (2005) Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. The International Journal of Biochemistry & Cell Biology 37:6, pages 1208-1218.
Crossref
CHENG-FENG LEE, CHUN-YI LIU, SHU-MEI CHEN, MARIANNA SIKORSKA, CHEN-YU LIN, TZU-LING CHEN & YAU-HUEI WEI. (2005) Attenuation of UV-Induced Apoptosis by Coenzyme Q 10 in Human Cells Harboring Large-Scale Deletion of Mitochondrial DNA . Annals of the New York Academy of Sciences 1042:1, pages 429-438.
Crossref
David González-Aragón, María I. Burón, Guillermo López-Lluch, María D. Hermán, Consuelo Gómez-Díaz, PlÁCido Navas & José M. Villalba. (2005) Coenzyme Q and the regulation of intracellular steady-state levels of superoxide in HL-60 cells. BioFactors 25:1-4, pages 31-41.
Crossref
ÁNgela Gavilán, Claudio Asencio, Juan Cabello, Juan C. Rodríguez-Aguilera, Ralf Schnabel & PlÁCido Navas. (2005) C. elegans knockouts in ubiquinone biosynthesis genes result in different phenotypes during larval development . BioFactors 25:1-4, pages 21-29.
Crossref
Shi Zhou. 2004. Nutritional Ergogenic Aids. Nutritional Ergogenic Aids 355 378 .
Arezoo Campbell & Stephen Bondy. 2004. Molecular Neurotoxicology. Molecular Neurotoxicology 107 121 .
Hanan M. Abd-El Gawad .Dalaal M. Abdallah .Hanan S. El-Abhar .. (2004) Rotenone-induced Parkinson`s Like Disease: Modulating Role of Coenzyme Q10. Journal of Biological Sciences 4:4, pages 568-574.
Crossref
Richard H. Myers. (2004) Huntington’s disease genetics. NeuroRX 1:2, pages 255-262.
Crossref
Wang-Tso Lee & Chen Chang. (2004) Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease. Progress in Neurobiology 72:2, pages 87-110.
Crossref
G. Bruneteau, S. Demeret & V. Meininger. (2004) Physiopathologie de la Sclérose Latérale Amyotrophique : approches thérapeutiques. Revue Neurologique 160:2, pages 235-241.
Crossref
E Knyihár-Csillik, B Csillik, M Pákáski, B Krisztin-Péva, E Dobó, E Okuno & L Vécsei. (2004) Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Neuroscience 126:4, pages 899-914.
Crossref
Andrea Ernst, Alexandra Stolzing, Grit Sandig & Tilman Grune. (2004) Antioxidants effectively prevent oxidation-induced protein damage in OLN 93 cells. Archives of Biochemistry and Biophysics 421:1, pages 54-60.
Crossref
S Sharma, M Kheradpezhou, S Shavali, H.El Refaey, J Eken, C Hagen & M Ebadi. 2004. Quinones and Quinone Enzymes, Part B. Quinones and Quinone Enzymes, Part B 488 509 .
. 2004. Management of Patients with Neuromuscular Disease. Management of Patients with Neuromuscular Disease 355 397 .
Mario E. Götz & Peter Riederer. 2004. Frontiers in Clinical Neuroscience. Frontiers in Clinical Neuroscience 1 19 .
Nathan Goodman, Kim McCormick, Dan Goldowitz, Emma Hockly, Carl Johnson, Bruce Kristal, Marcy MacDonald, Ray Truant & Minka van Beuzekom. (2003) Plans for HDBase—a research community website for Huntington's Disease. Clinical Neuroscience Research 3:3, pages 197-217.
Crossref
M. FLINT BEAL. (2006) Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease. Annals of the New York Academy of Sciences 991:1, pages 120-131.
Crossref
Claudio Asencio, Juan C. Rodríguez-Aguilera, Macarena Ruiz-Ferrer, Jordana Vela & Plácido Navas. (2003) Silencing of ubiquinone biosynthesis genes extends life span in Caenorhabditis elegans . The FASEB Journal 17:9, pages 1135-1137.
Crossref
Martin R. Turner & P. Nigel Leigh. 2003. Motor Neuron Disorders. Motor Neuron Disorders 497 544 .
Michael T. Lin & M. Flint Beal. (2003) The oxidative damage theory of aging. Clinical Neuroscience Research 2:5-6, pages 305-315.
Crossref
Juan C. Rodríguez-Aguilera, Claudio Asencio, Macarena Ruiz-Ferrer, Jordana Vela & Plácido Navas. (2003) Caenorhabditis elegans ubiquinone biosynthesis genes . BioFactors 18:1-4, pages 237-244.
Crossref
Čestmír Zita, Kim Overvad, Svend Aage Mortensen, Christian Dan Sindberg, Sven Moesgaard & Douglas A. Hunter. (2003) Serum coenzyme Q 10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q 10 for two months in a randomised controlled study . BioFactors 18:1-4, pages 185-193.
Crossref
Marianna Sikorska, Henryk Borowy-Borowski, Bogdan Zurakowski & P. Roy Walker. (2003) Derivatised α-tocopherol as α CoQ 10 carrier in a novel water-soluble formulation . BioFactors 18:1-4, pages 173-183.
Crossref
T. Menke, G. Gille, F. Reber, B. Janetzky, W. Andler, R. H. W. Funk & H. Reichmann. (2003) Coenzyme Q 10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential . BioFactors 18:1-4, pages 65-72.
Crossref
Amy Cameron & Jeffrey Rosenfeld. (2002) Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders. Current Opinion in Clinical Nutrition and Metabolic Care 5:6, pages 631-643.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.